Erector Spinae Plane Versus Transversus Abdominis Plane Block for Pain Control
Ultrasound-guided Erector Spinae Plane Block Versus Transversus Abdominis Plane Block for Pain Control After Cesarean Section in Obese and Morbidly Obese Women
1 other identifier
interventional
68
1 country
1
Brief Summary
The present stratified randomized study aimed to compare the analgesic efficacy and safety profile of ESPB and TAPB used for postoperative pain management in obese and morbidly obese women undergoing CS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2024
CompletedFirst Posted
Study publicly available on registry
March 5, 2024
CompletedStudy Start
First participant enrolled
March 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2024
CompletedMarch 5, 2024
February 1, 2024
6 months
February 20, 2024
February 27, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
postoperative time to rescue analgesia requirement
Time
24 hours
Study Arms (4)
Obese Spinae Plane Block
ACTIVE COMPARATORSpinae Plane Block for pain control
Obese Transversus Abdominis Plane Block
ACTIVE COMPARATORTransversus Abdominis Plane Block for pain control.
Morbidly Obese Spinae Plane Block
ACTIVE COMPARATORSpinae Plane Block for pain control
Morbidly Obese Transversus Abdominis Plane Block
ACTIVE COMPARATORTransversus Abdominis Plane Block for pain control.
Interventions
Ultrasound-guided pain block after cesarean section
Ultrasound machine used to guide the nerve block.
Eligibility Criteria
You may qualify if:
- ASA I-II women scheduled for elective CS under intrathecal anesthesia.
You may not qualify if:
- had local infection, bleeding disorder or known allergy to any of the study medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Al-Azhar University
Asyut, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Warda Ali
Al-Azhar University, Assiut, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 20, 2024
First Posted
March 5, 2024
Study Start
March 10, 2024
Primary Completion
September 10, 2024
Study Completion
September 10, 2024
Last Updated
March 5, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share